Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.

Nathan HamblyMohammed Abdul Malik Farooqi Anna Dvorkin-GhevaKathryn DonohoeKristopher GarlickCiaran ScallanSy Giin ChongSarah MacIsaacDeborah Assayag Kerri A JohannsonCharlene D FellVeronica MarcouxHelene ManganasJulie MorissetAlessia ComesJolene H FisherShane ShaperaAndrea S GershonTeresa ToAlyson W WongMohsen SadatsafaviPierce G WilcoxAndrew J HalaykoNasreen KhalilP Gerard CoxLuca RicheldiChristopher J RyersonMartin R J Kolb

Published in: The European respiratory journal (2022)

Progression is common in patients with fibrotic ILD, and is similarly prevalent in HP and IPF. Routinely collected variables help identify patients at risk for progression and may guide therapeutic strategies.

Keyphrases

interstitial lung disease
systemic sclerosis
idiopathic pulmonary fibrosis
rheumatoid arthritis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
multiple sclerosis
risk factors
prognostic factors
peritoneal dialysis